Filing Analysis
Lifecore Biomedical reported the results of its 2026 Annual Meeting of Stockholders held on June 4, 2026. Key outcomes include the election of nine directors, the ratification of KPMG LLP as the independent auditor, and the approval of the 2026 Stock Incentive Plan.
📋 Key Facts
- The 2026 Stock Incentive Plan was approved and will become effective on October 16, 2026, replacing the 2019 Plan.
- The 2026 Plan authorizes the issuance of 2,500,000 shares of Common Stock, plus any forfeited or cancelled shares from the 2019 Plan.
- Nine directors were elected: seven by common and preferred stockholders combined, and two (Jason Aryeh and Christopher S. Kiper) solely by Series A Preferred Stockholders.
- KPMG LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
- Executive compensation was approved via a non-binding advisory vote.
Lifecore Biomedical, Inc. reported its consolidated financial results for the first quarter ended March 31, 2026, and released an updated investor presentation.
📋 Key Facts
- The company announced Q1 2026 financial results on May 6, 2026.
- A press release detailing the results was furnished as Exhibit 99.1.
- An investor presentation was made available on the company's website and furnished as Exhibit 99.2.
- The report was signed by Chief Financial Officer Ryan D. Lake.
Lifecore Biomedical, Inc. announced its financial results for the fourth quarter and transition period ended December 31, 2025, and provided an updated investor presentation.
📋 Key Facts
- Announced Q4 and transition period financial results on March 16, 2026.
- Furnished a press release as Exhibit 99.1.
- Furnished an investor presentation as Exhibit 99.2.
- The transition period ended December 31, 2025.
Lifecore Biomedical has scheduled its 2026 Annual Meeting of Stockholders for June 4, 2026, following a change in its fiscal year end to December 31. This shift requires a new deadline of March 16, 2026, for shareholders to submit proposals or director nominations.
📋 Key Facts
- Fiscal year changed from ending the last Sunday of May to December 31, effective for the period ending December 31, 2025.
- 2026 Annual Meeting date set for June 4, 2026.
- The 2025 Annual Meeting was held on October 29, 2025; the new date is more than 30 days from the anniversary of the prior meeting.
- New deadline for shareholder proposals and director nominations is March 16, 2026.